Dr. Thomas S. Potter, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4366 Kukui Grove St, Suite 201, Lihue, HI 96766 Phone: 808-246-6904 Fax: 808-246-6081 |
News Archive
University of Florida researchers have identified a set of proteins that appear to signal the presence of bladder cancer, a discovery they hope will lead to a simple, fast and noninvasive test that can detect the disease early.
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
HHS Secretary Kathleen Sebelius today announced 15 awards totaling $9 million to support Preventive Medicine Residency Programs at accredited schools of public health, schools of medicine, and hospitals. Of these funds, nearly $6.7 million is part of the $200 million appropriated to HHS' Health Resources and Services Administration under the American Recovery and Reinvestment Act of 2009 to address the nation's health care workforce shortages.
One of the biggest longitudinal research studies of its kind in the world led by The Hospital for Sick Children (SickKids) and the Centre for Addiction and Mental Health (CAMH) suggests that positive outcomes for children with autism spectrum disorder (ASD) are more common than previously thought.
Signal Genetics announced today, at the American Society of Hematology Annual Meeting, that the Company is launching its next generation Multiple Myeloma product, MyPRS Plus, effective January 1, 2012.
› Verified 7 days ago